The role of intraarticular injections of hyaluronic acid in joint pain relief in hemophilic arthropathy

References

• Miller LE, Bhattacharyya S, Parrish WR, et al. Safety of intra-articular hyaluronic acid for knee osteoarthritis: systematic review and meta-analysis of randomized trials involving more than 8,000 patients. Cartilage. 2021;13(Suppl. 1):351S–363S. doi: 10.1177/1947603519888783
   PubMed Web of Science ®Google Scholar
• Mojica ES, Markus DH, Hurley ET, et al. Estimated time to maximum medical improvement of intra-articular injections in the treatment of knee osteoarthritis-a systematic review. Arthroscopy: The Journal Of Arthroscopic & Related Surgery. 2022;38(3):980–988.e4. doi: 10.1016/j.arthro.2021.08.026
   PubMed Web of Science ®Google Scholar
• Singh H, Knapik DM, Polce EM, et al. Relative efficacy of intra-articular injections in the treatment of knee osteoarthritis: a systematic review and network meta-analysis. Am J Sports Med. 2022;50(11):3140–3148. doi: 10.1177/03635465211029659
   PubMed Web of Science ®Google Scholar
• Ferkel E, Manjoo A, Martins D, et al. Intra-articular hyaluronic acid treatments for knee osteoarthritis: a systematic review of product properties. Cartilage. 2023Jun; 14:19476035231154530. Online ahead of print. PMID: 37314014. doi: 10.1177/19476035231154530
   Google Scholar
• De Lucia O, Murgo A, Pregnolato F, et al. Hyaluronic acid injections in the treatment of osteoarthritis secondary to primary inflammatory rheumatic diseases: a systematic review and qualitative synthesis. Adv Ther. 2020;37(4):1347–1359. doi: 10.1007/s12325-020-01256-7
   PubMed Web of Science ®Google Scholar
• Martin-Alarcon L, Schmidt TA. Rheological effects of macromolecular interactions in synovial fluid. Biorheology. 2016;53(2):49–67. doi: 10.3233/BIR-15104
   PubMed Web of Science ®Google Scholar
• Altman RD, Manjoo A, Fierlinger A, et al. The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review. BMC Musculoskelet Disord. 2015;16(1):321. doi: 10.1186/s12891-015-0775-z
   PubMedGoogle Scholar
• McArthur BA, Dy CJ, Fabricant PD, et al. Long term safety, efficacy, and patient acceptability of hyaluronic acid injection in patients with painful osteoarthritis of the knee. Patient Prefer Adherence. 2012;6:905–910. doi: 10.2147/PPA.S27783
   PubMed Web of Science ®Google Scholar
• Nicholls M, Manjoo A, Shaw P, et al. Rheological properties of commercially available hyaluronic acid products in the United States for the treatment of osteoarthritis knee pain. Clin Med Insights Arthritis Musculoskelet Disord. 2018;11:1179544117751622. doi: 10.1177/1179544117751622
   Web of Science ®Google Scholar
• Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578–1589. doi: 10.1016/j.joca.2019.06.011
   PubMed Web of Science ®Google Scholar
• Bruyere O, Honvo G, Veronese N, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO). Semin Arthritis Rheum. 2019;49(3):337–350. doi: 10.1016/j.semarthrit.2019.04.008
   PubMed Web of Science ®Google Scholar
• Trojian TH, Concoff AL, Joy SM, et al. AMSSM scientific statement concerning viscosupplementation injections for knee osteoarthritis: importance for individual patient outcomes. Clin J Sport Med. 2016;26(1):1–11. doi: 10.1097/JSM.0000000000000274
   PubMed Web of Science ®Google Scholar
• Rillo O, Riera H, Acosta C, et al. PANLAR consensus recommendations for the management in osteoarthritis of hand, hip, and knee. J Clin Rheumatol. 2016;22(7):345–354. doi: 10.1097/RHU.0000000000000449
   PubMed Web of Science ®Google Scholar
• Steinmeyer J, Bock F, Stove J, et al. Pharmacological treatment of knee osteoarthritis: special considerations of the new German guideline. Orthop Rev (Pavia). 2018;10(4):7782. doi: 10.4081/or.2018.7782
   PubMed Web of Science ®Google Scholar
• Sinusas K. Osteoarthritis: diagnosis and treatment. Am Fam Physician. 2012;85(1):49–56.
   PubMed Web of Science ®Google Scholar
• Brown GA. AAOS clinical practice guideline: treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. J Am Acad Orthop Surg. 2013;21(9):577–579. doi: 10.5435/00124635-201309020-00009
   PubMed Web of Science ®Google Scholar
• Kolasinski SL, Neogi T, Hochberg MC, et al. American college of rheumatology/arthritis foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis & Rheumat. 2020;72(2):220–233. 2019. doi: 10.1002/art.41142
   PubMed Web of Science ®Google Scholar
• Altman RD, Bedi A, Karlsson J, et al. Product differences in intra-articular hyaluronic acids for osteoarthritis of the knee. Am J Sports Med. 2016;44(8):2158–2165. doi: 10.1177/0363546515609599
   PubMed Web of Science ®Google Scholar
• Bhandari M, Bannuru RR, Babins EM, et al. Intra-articular hyaluronic acid in the treatment of knee osteoarthritis: a Canadian evidence-based perspective. Ther Adv Musculoskelet Dis. 2017;9(9):231–246. doi: 10.1177/1759720X17729641
   PubMed Web of Science ®Google Scholar
• Vannabouathong C, Bhandari M, Bedi A, et al. Nonoperative treatments for knee osteoarthritis: an evaluation of treatment characteristics and the intra-articular placebo effect: a systematic review. JBJS Rev. 2018;6(7):e5. doi: 10.2106/JBJS.RVW.17.00167
   PubMed Web of Science ®Google Scholar
• Webner D, Huang Y, Hummer CD. 3rd. Intraarticular hyaluronic acid preparations for knee osteoarthritis: are some better than others? Cartilage. 2021;13(Suppl. 1):1619S–1636S. doi: 10.1177/19476035211017320
   PubMed Web of Science ®Google Scholar
• Ohashi Y, Uchida K, Fukushima K, et al. Mechanisms of peripheral and central sensitization in osteoarthritis pain. Cureus. 2023 Feb 22;15(2):e35331. doi: 10.7759/cureus.35331
   PubMed Web of Science ®Google Scholar
• Rodriguez-Merchan EC. Effects of hemophilia on articulations of children and adults. Clin Orthop Relat Res. 1996;328:7–13. doi: 10.1097/00003086-199607000-00003
   PubMed Web of Science ®Google Scholar
• Rodriguez-Merchan EC. Management of the orthopaedic complications of haemophilia. J Bone Joint Surg Br. 1998;80(2):191–196. doi: 10.1302/0301-620X.80B2.0800191
   PubMedGoogle Scholar
• Valentino LA. Blood-induced joint disease: the pathophysiology of hemophilic arthropathy. J Thromb Haemost. 2010;8(9):1895–1902. doi: 10.1111/j.1538-7836.2010.03962.x
   PubMed Web of Science ®Google Scholar
• Rodriguez-Merchan EC. Musculo-skeletal manifestations of haemophilia. Blood Rev. 2016;30(5):401–409. doi: 10.1016/j.blre.2016.04.008
   PubMed Web of Science ®Google Scholar
• Valentino LA, Baker JR, Butler R, et al. Integrated hemophilia patient care via a national network of care centers in the United States: a model for rare coagulation disorders. J Blood Med. 2021;12:897–911. doi: 10.2147/JBM.S325031
   PubMed Web of Science ®Google Scholar
• Nogami K, Shima M. Current and future therapies for haemophilia-beyond factor replacement therapies. Br J Haematol. 2023;200(1):23–34. doi: 10.1111/bjh.18379
   PubMedGoogle Scholar
• Keam SJ. Concizumab: first approval. Drugs. 2023;83(11):1053–1059. doi: 10.1007/s40265-023-01912-6
   PubMed Web of Science ®Google Scholar
• Négrier C, Mahlangu J, Lehle M, et al. Emicizumab in people with moderate or mild haemophilia a (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study. Lancet Haematol. 2023;10(3):e168–e177. doi: 10.1016/S2352-3026(22)00377-5
   PubMed Web of Science ®Google Scholar
• Pasca S, Zanon E, Mannucci PM, et al. Emicizumab in acquired hemophilia A: pros and cons of a new approach to the prevention and treatment of bleeding. Blood Transfus. 2023 Feb 7. Online ahead of print. PMID: 36795341. 10.2450/2023.0247-22
   Google Scholar
• Young G, Lenting PJ, Croteau SE, et al. Antithrombin lowering in hemophilia: a closer look at fitusiran. Res Pract Thromb Haemost. 2023;7(4):100179. doi: 10.1016/j.rpth.2023.100179
   PubMed Web of Science ®Google Scholar
• Jimenez-Yuste V, Alvarez-Roman MT. Fitusiran prophylaxis in severe haemophilia without inhibitors. Lancet Haematol. 2023;10(5):e308–e309. doi: 10.1016/S2352-3026(23)00057-1
   PubMed Web of Science ®Google Scholar
• Steen Carlsson K, Winding B, Astermark J, et al. High use of pain, depression, and anxiety drugs in hemophilia: more than 3000 people with hemophilia in an 11-year Nordic registry study. Res Pract Thromb Haemost. 2023;7(2):100061. doi: 10.1016/j.rpth.2023.100061
   PubMed Web of Science ®Google Scholar
• Chantrain VA, Lambert C, De Smet P, et al. Pain interferes with daily activities, emotions and sleep in adults with severe, moderate and mild haemophilia: a national cross-sectional survey. Haemophilia. 2023;29(2):521–529. doi: 10.1111/hae.14747
   PubMed Web of Science ®Google Scholar
• Khair K, McLaughlin P, Roussel N, et al. Prevalence and perceptions of pain in people with haemophilia: a UK study. Haemophilia. 2023 Sep 11. Online ahead of print. PMID: 37694815. 10.1111/hae.14860
   Web of Science ®Google Scholar
• Rodriguez-Merchan EC. Treatment of musculo-skeletal pain in haemophilia. Blood Rev. 2018;32(2):116–121. doi: 10.1016/j.blre.2017.09.004
   PubMed Web of Science ®Google Scholar
• Wallny T, Brackmann HH, Semper H, et al. Intra-articular hyaluronic acid in the treatment of haemophilic arthropathy of the knee. Clinical, radiological and sonographical assessment. Haemophilia. 2000;6(5):566–570. doi: 10.1046/j.1365-2516.2000.00413.x
   PubMed Web of Science ®Google Scholar
• Fernandez-Palazzi F, Viso R, Boadas A, et al. Intra-articular hyaluronic acid in the treatment of haemophilic chronic arthropathy. Haemophilia. 2002;8(3):375–381. doi: 10.1046/j.1365-2516.2002.00627.x
   PubMed Web of Science ®Google Scholar
• Carulli C, Civinini R, Martini C, et al. Viscosupplementation in haemophilic arthropathy: a long-term follow-up study. Haemophilia. 2012;18(3):e210–e214. doi: 10.1111/j.1365-2516.2011.02654.x
   PubMed Web of Science ®Google Scholar
• Rodriguez-Merchan EC. Intra-articular injections of hyaluronic acid (viscosupplementation) in the haemophilic knee. Blood Coagul Fibrinolysis. 2012;23(7):580–583. doi: 10.1097/MBC.0b013e328357b36a
   PubMed Web of Science ®Google Scholar
• Carulli C, Matassi F, Civinini R, et al. Intra-articular injections of hyaluronic acid induce positive clinical effects in knees of patients affected by haemophilic arthropathy. Knee. 2013;20(1):36–39. doi: 10.1016/j.knee.2012.05.006
   PubMed Web of Science ®Google Scholar
• Carulli C, Rizzo AR, Innocenti M, et al. Viscosupplementation in symptomatic haemophilic arthropathy of the knee and ankle: experience with a high molecular weight hyaluronic acid. Haemophilia. 2020;26(4):e198–e200. doi: 10.1111/hae.13979
   PubMed Web of Science ®Google Scholar
• Poursac N, Lafarie‐Castet S, Loustau C. Efficacy on pain of a single injection of hyaluronic acid in hemophilic arthropathy of the ankle: a prospective study. Haemophilia. 2018;24(Suppl. 1):111‐112.
   Google Scholar
• Buccheri E, Avola M, Vitale N, et al. Haemophilic arthropathy: a narrative review on the use of intra-articular drugs for arthritis. Haemophilia. 2019;25(6):919–927. doi: 10.1111/hae.13857
   PubMed Web of Science ®Google Scholar
• Li TY, Wu YT, Chen LC, et al. An exploratory comparison of single intra-articular injection of platelet-rich plasma vs hyaluronic acid in treatment of haemophilic arthropathy of the knee. Haemophilia. 2019;25(3):484‐492. doi: 10.1111/hae.13711
   Web of Science ®Google Scholar
• Duan W, Su X, Yu Z, et al. No benefit to platelet-rich plasma over placebo injections in terms of pain or function in patients with hemophilic knee arthritis: a randomized trial. Clin Orthop Relat Res. 2022;480(12):2361‐2370. doi: 10.1097/CORR.0000000000002264
   PubMed Web of Science ®Google Scholar
• Taylor S, David J, Partington K, et al. A single centre, open label, pilot study evaluating the effect of intra-articular hyaluronic acid injection on pain and functionality when injected into the ankle (tibio-talar and sub-talar) joint in patients with haemophilic arthropathy. Haemophilia. 2022;28(6):e181–e188. doi: 10.1111/hae.14639
   PubMed Web of Science ®Google Scholar
• van Vulpen LFD, Thomas S, Keny SA, et al. Synovitis and synovectomy in haemophilia. Haemophilia. 2021;27(Suppl 3):96–102. doi: 10.1111/hae.14025
   PubMedGoogle Scholar
• Rodriguez-Merchan EC. Synovitis in hemophilia: preventing, detecting, and treating joint bleeds. Expert Rev Hematol. 2023;16(7):525–534. doi: 10.1080/17474086.2023.2209717
   PubMed Web of Science ®Google Scholar
• Suh HC, Kim DK, Kang SH, et al. Clinical and radiological evaluation after chemical synovectomy with rifampicin in hemophilic arthropathy: Korean experience with a 2-week interval protocol. Ann Rehabil Med. 2018;42(3):449–456. doi: 10.5535/arm.2018.42.3.449
   PubMedGoogle Scholar
• Thomas S, Mendes JD, Souza SA, et al. Radioactive synovectomy with 90 yttrium and 153 samarium hydroxyapatite in haemophilic joints: preliminary study on radiation safety. Haemophilia. 2013;19(4):632–636. doi: 10.1111/hae.12122
   PubMed Web of Science ®Google Scholar
• Rodriguez-Merchan EC, De la Corte-Rodriguez H, Alvarez-Roman MT, et al. Radiosynovectomy for the treatment of chronic hemophilic synovitis: an old technique, but still very effective. J Clin Med. 2022;11(24):7475. doi: 10.3390/jcm11247475
   PubMed Web of Science ®Google Scholar
• de Almeida AM, de Rezende MU, Cordeiro FG, et al. Arthroscopic partial anterior synovectomy of the knee on patients with haemophilia. Knee Surg Sports Traumatol Arthrosc. 2015;23(3):785–791. doi: 10.1007/s00167-013-2706-6
   PubMed Web of Science ®Google Scholar
• Zhang T, Huang S, Xu S, et al. Clinical outcomes of arthroscopic synovectomy for adolescent or young adult patients with advanced haemophilic arthropathy. Exp Ther Med. 2018;16(5):3883–3888. doi: 10.3892/etm.2018.6709
   PubMed Web of Science ®Google Scholar